Cargando…

Antifungal Prophylaxis in Acute Myeloid Leukemia: New Drugs, New Challenges?: Summary of the EHA Guideline on Antifungal Prophylaxis in Adult Patients With Acute Myeloid Leukemia Treated With Novel-targeted Therapies

Detalles Bibliográficos
Autores principales: Stemler, Jannik, Cornely, Oliver A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9208892/
https://www.ncbi.nlm.nih.gov/pubmed/35747590
http://dx.doi.org/10.1097/HS9.0000000000000742
_version_ 1784729811669745664
author Stemler, Jannik
Cornely, Oliver A.
author_facet Stemler, Jannik
Cornely, Oliver A.
author_sort Stemler, Jannik
collection PubMed
description
format Online
Article
Text
id pubmed-9208892
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Lippincott Williams & Wilkins
record_format MEDLINE/PubMed
spelling pubmed-92088922022-06-22 Antifungal Prophylaxis in Acute Myeloid Leukemia: New Drugs, New Challenges?: Summary of the EHA Guideline on Antifungal Prophylaxis in Adult Patients With Acute Myeloid Leukemia Treated With Novel-targeted Therapies Stemler, Jannik Cornely, Oliver A. Hemasphere Editorial Lippincott Williams & Wilkins 2022-06-17 /pmc/articles/PMC9208892/ /pubmed/35747590 http://dx.doi.org/10.1097/HS9.0000000000000742 Text en Copyright © 2022 the Author(s). Published by Wolters Kluwer Health, Inc. on behalf of the European Hematology Association. https://creativecommons.org/licenses/by/4.0/This is an open access article distributed under the Creative Commons Attribution License 4.0 (CCBY) (https://creativecommons.org/licenses/by/4.0/) , which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Editorial
Stemler, Jannik
Cornely, Oliver A.
Antifungal Prophylaxis in Acute Myeloid Leukemia: New Drugs, New Challenges?: Summary of the EHA Guideline on Antifungal Prophylaxis in Adult Patients With Acute Myeloid Leukemia Treated With Novel-targeted Therapies
title Antifungal Prophylaxis in Acute Myeloid Leukemia: New Drugs, New Challenges?: Summary of the EHA Guideline on Antifungal Prophylaxis in Adult Patients With Acute Myeloid Leukemia Treated With Novel-targeted Therapies
title_full Antifungal Prophylaxis in Acute Myeloid Leukemia: New Drugs, New Challenges?: Summary of the EHA Guideline on Antifungal Prophylaxis in Adult Patients With Acute Myeloid Leukemia Treated With Novel-targeted Therapies
title_fullStr Antifungal Prophylaxis in Acute Myeloid Leukemia: New Drugs, New Challenges?: Summary of the EHA Guideline on Antifungal Prophylaxis in Adult Patients With Acute Myeloid Leukemia Treated With Novel-targeted Therapies
title_full_unstemmed Antifungal Prophylaxis in Acute Myeloid Leukemia: New Drugs, New Challenges?: Summary of the EHA Guideline on Antifungal Prophylaxis in Adult Patients With Acute Myeloid Leukemia Treated With Novel-targeted Therapies
title_short Antifungal Prophylaxis in Acute Myeloid Leukemia: New Drugs, New Challenges?: Summary of the EHA Guideline on Antifungal Prophylaxis in Adult Patients With Acute Myeloid Leukemia Treated With Novel-targeted Therapies
title_sort antifungal prophylaxis in acute myeloid leukemia: new drugs, new challenges?: summary of the eha guideline on antifungal prophylaxis in adult patients with acute myeloid leukemia treated with novel-targeted therapies
topic Editorial
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9208892/
https://www.ncbi.nlm.nih.gov/pubmed/35747590
http://dx.doi.org/10.1097/HS9.0000000000000742
work_keys_str_mv AT stemlerjannik antifungalprophylaxisinacutemyeloidleukemianewdrugsnewchallengessummaryoftheehaguidelineonantifungalprophylaxisinadultpatientswithacutemyeloidleukemiatreatedwithnoveltargetedtherapies
AT cornelyolivera antifungalprophylaxisinacutemyeloidleukemianewdrugsnewchallengessummaryoftheehaguidelineonantifungalprophylaxisinadultpatientswithacutemyeloidleukemiatreatedwithnoveltargetedtherapies